178 results on '"Bongard, Emily"'
Search Results
2. Conditional versus non-conditional incentives to maximise return of participant completed questionnaires in clinical trials: a cluster randomised study within a trial
3. Diagnostic performance of the Idylla™ respiratory panel for molecular detection of influenza A/B in patients presenting to primary care with influenza-like illness during 3 consecutive influenza seasons
4. Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis
5. Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial
6. Uncomplicated urinary tract infection in primary care : evaluation of point of care tests and patient management
7. Clinical diagnosis of SARS-CoV-2 infection: An observational study of respiratory tract infection in primary care in the early phase of the pandemic
8. Oseltamivir bij infectie door een humaan coronavirus: Post-hocanalyse van gegevens uit 2016-2018
9. Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trial
10. Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness:economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries
11. Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries
12. Clinical diagnosis of SARS-CoV-2 infection: An observational study of respiratory tract infection in primary care in the early phase of the pandemic
13. Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European Countries
14. Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries.
15. Managing Penicillin Allergy in Primary Care: An Important but Neglected Aspect of Antibiotic Stewardship
16. Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries.
17. Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study
18. Point-of care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care:a prospective audit in 18 European countries
19. Clinical presentation and disease course in patients with flu-like illness:does microbiological aetiology matter?
20. Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care:A randomized controlled trial secondary analysis in 15 European countries
21. Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
22. Point of care testing, antibiotic prescribing and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 European countries
23. Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countries
24. Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
25. Mixed-methods evaluation of a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice
26. Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 European countries
27. Clinical presentation, microbiological aetiology and disease course in patients with flu-like illness: a post hoc analysis of randomised controlled trial data
28. Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countries
29. Antibiotics and uncertainty of diagnosis in viral respiratory infections: Point‐prevalence survey across 15 European countries.
30. Primary care for patients with respiratory tract infection before and early on in the COVID-19 pandemic: an observational study in 16 European countries
31. Primary care for patients with respiratory tract infection before and early on in the COVID-19 pandemic:an observational study in 16 European countries
32. Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries:A Descriptive Analysis Alongside the Randomised Controlled ALIC(4)E Trial
33. Diagnostic performance of the IdyllaTM respiratory panel for molecular detection of influenza A/B in patients presenting to primary care with influenza-like illness during 3 consecutive influenza seasons
34. Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial
35. Primary care for patients with respiratory tract infection before and early on in the COVID-19 pandemic: an observational study in 16 European countries
36. Synthesis and structure–activity relationship of 3-phenylquinoxaline 1,4-di- N-oxide derivatives as antimalarial agents
37. Conditional versus Non-Conditional Incentives to Maximise Return of Participant Completed Questionnaires in Clinical Trials: A Cluster Randomised Study Within a Trial
38. Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
39. Oseltamivir voor griepachtige aandoeningen : Een pragmatisch gerandomiseerd gecontroleerd onderzoek
40. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care : an open-label, pragmatic, randomised controlled trial
41. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care:an open-label, pragmatic, randomised controlled trial
42. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial
43. Oseltamivir voor griepachtige aandoeningen: Een pragmatisch gerandomiseerd gecontroleerd onderzoek.
44. Oseltamivir bij infectie door een humaan coronavirus: Post-hocanalyse van gegevens uit 2016-2018
45. Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018
46. Anti-malarial activity of N6-modified purine analogues
47. Clinical prediction of laboratory-confirmed influenza in adults with influenza-like illness in primary care. A randomized controlled trial secondary analysis in 15 European countries.
48. Point-of-care testing, antibiotic prescribing, and prescribing confidence for respiratory tract infections in primary care: a prospective audit in 18 European countries.
49. A study to evaluate diagnostic tests used at the point of care for improving antibiotic prescribing for patients with respiratory tract infections in primary care in Europe
50. Developing a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice and subsequently change antibiotic use
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.